Related content

Biological activities of N 6 ,C8-disubstituted adenosine derivatives as partial agonists at rat brain adenosine A 1 receptors

By Lorenzen A.   Sebastiao A.M.   Sellink A.   Vogt H.   Schwabe U.   Ribeiro J.A.   IJzerman A.P.  

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 299-307

Elsevier

Access to resources Recommend Favorite

(E)-1-(Heterocyclyl or cyclohexyl)-2-[1,3,7-trisubstituted (xanthin-8-yl)] ethenes as A 2a adenosine receptor antagonists

By Del Giudice M.   Borioni A.   Mustazza C.   Gatta F.   Dionisotti S.   Zocchi C.   Ongini E.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 1, 1996-01 ,pp. : 59-63

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of A₂ and A₃ adenosine receptor: a review of novel patented ligands

By Federico Stephanie   Spalluto Giampiero  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. : 369-390

Informa Healthcare

Access to resources Recommend Favorite

Synthesis of 3-phenyl-4-phenylvinyl Benzopyranones and the Corresponding 2,2-dimethyl-benzopyrans with Structural Similarity to Estradiol, as Estrogen Receptor Ligands

By  

Medicinal Chemistry, Vol. 3, Iss. 5, 2007-09 ,pp. : 446-454

Bentham Science Publishers

Access to resources Recommend Favorite

Recent improvements in the field of A₃ adenosine receptor ligands

By Baraldi Pier Giovanni   Fruttarolo Francesca   Tabrizi Mojgan Aghazadeh   Romagnoli Romeo   Preti Delia   Carriòn María Dora   Iaconinoto Antonietta   Borea Pier Andrea  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1507-1519

Informa Healthcare

Access to resources Recommend Favorite